Armata Pharmaceuticals Stock Alpha and Beta Analysis
| ARMP Stock | USD 6.19 0.21 3.51% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Armata Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Armata Pharmaceuticals over a specified time horizon. Remember, high Armata Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Armata Pharmaceuticals' market risk premium analysis include:
Beta (1.39) | Alpha 1.8 | Risk 7.46 | Sharpe Ratio 0.0718 | Expected Return 0.54 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Armata Pharmaceuticals Backtesting, Armata Pharmaceuticals Valuation, Armata Pharmaceuticals Correlation, Armata Pharmaceuticals Hype Analysis, Armata Pharmaceuticals Volatility, Armata Pharmaceuticals History and analyze Armata Pharmaceuticals Performance. Armata Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Armata Pharmaceuticals market risk premium is the additional return an investor will receive from holding Armata Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Armata Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Armata Pharmaceuticals' performance over market.| α | 1.80 | β | -1.39 |
Armata Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Armata Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Armata Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Armata Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Armata Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Armata Pharmaceuticals shares will generate the highest return on investment. By understating and applying Armata Pharmaceuticals stock market price indicators, traders can identify Armata Pharmaceuticals position entry and exit signals to maximize returns.
Armata Pharmaceuticals Return and Market Media
The median price of Armata Pharmaceuticals for the period between Sat, Oct 25, 2025 and Fri, Jan 23, 2026 is 6.21 with a coefficient of variation of 14.64. The daily time series for the period is distributed with a sample standard deviation of 0.89, arithmetic mean of 6.09, and mean deviation of 0.66. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | What is the fair value estimate for Armata Pharmaceuticals Inc. stock in 2025 - Volume Spike Real-Time Stock Price Movement Reports - newser.com | 11/11/2025 |
2 | Can Armata Pharmaceuticals Inc. stock surprise with earnings upside - 2025 Big Picture Free AI Powered Buy and Sell Recommendations - newser.com | 11/14/2025 |
3 | Can Armata Pharmaceuticals Inc. stock retain market dominance - 2025 Biggest Moves Safe Swing Trade Setups - newser.com | 11/17/2025 |
4 | Can Armata Pharmaceuticals Inc. stock attract ESG investments - Trade Volume Summary High Accuracy Trade Signal Alerts - newser.com | 11/20/2025 |
5 | Will Armata Pharmaceuticals Inc. stock announce special dividend - Bull Run Real-Time Chart Breakout Alerts - Newser | 12/04/2025 |
6 | How Armata Pharmaceuticals Inc. stock reacts to bond yields - 2025 Volume Leaders High Yield Equity Trading Tips - Blm Sonu Canavar | 12/19/2025 |
7 | Will Armata Pharmaceuticals Inc. stock continue dividend increases - 2025 Price Targets Community Consensus Trade Alerts - ulpravda.ru | 01/08/2026 |
About Armata Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Armata or other stocks. Alpha measures the amount that position in Armata Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Dividend Yield | 0.0166 | 0.0175 | Price To Sales Ratio | 14.87 | 14.13 |
Armata Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Armata Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Armata Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Armata Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Armata Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Armata Pharmaceuticals' management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Armata Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Armata Stock Analysis
When running Armata Pharmaceuticals' price analysis, check to measure Armata Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Armata Pharmaceuticals is operating at the current time. Most of Armata Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Armata Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Armata Pharmaceuticals' price. Additionally, you may evaluate how the addition of Armata Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.